Literature DB >> 20962567

Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.

Wen-Hung Chung1, Shuen-Iu Hung.   

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening adverse reactions, which could be induced by a variety of drugs. It was proposed that human leukocyte antigen (HLA)-restricted presentation of antigens (drugs or their metabolites) to T lymphocytes initiates the immune reactions of SJS/TEN. However, the genetic susceptibility and the exact pathogenesis were not clear until the recent studies. We first identified that HLA-B*1502 is strongly associated with carbamazepine (CBZ)-induced SJS/TEN and HLA-B*5801 with allopurinol-SJS/TEN in Han Chinese. The same associations had been validated across different human populations. For the downstream danger signals, Fas-Fas ligand (FasL) and perforin/granzyme B had been advocated as cytotoxic mediators for keratinocyte death in SJS/TEN. However, expression levels of these cytotoxic proteins from the skin lesions were too low to explain the distinct and extensive epidermal necrosis. Our recent study identified that the granulysin, a cytotoxic protein released from cytotoxic T cells or natural killer (NK) cells, is a key mediator for disseminated keratinocyte death in SJS/TEN. This article aims to provide an overview of both of the genomic and immunologic perspectives of SJS/TEN. These studies give us a better understanding of the immune mechanisms, biomarkers for disease prevention and early diagnosis, as well as providing the therapeutic targets for the treatments of SJS/TEN.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962567     DOI: 10.2332/allergolint.10-RAI-0261

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  12 in total

1.  Carbamazepine hypersensitivity: progress toward predicting the unpredictable.

Authors:  Barry E Gidal
Journal:  Epilepsy Curr       Date:  2011-11       Impact factor: 7.500

2.  Data Mining FAERS to Analyze Molecular Targets of Drugs Highly Associated with Stevens-Johnson Syndrome.

Authors:  Keith K Burkhart; Darrell Abernethy; David Jackson
Journal:  J Med Toxicol       Date:  2015-06

Review 3.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

4.  Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan.

Authors:  David Hui-Kang Ma; Tsung-Ying Tsai; Li-Yen Pan; Shin-Yi Chen; Ching-Hsi Hsiao; Lung-Kun Yeh; Hsin-Yuan Tan; Chun-Wei Lu; Chun-Bing Chen; Wen-Hung Chung
Journal:  Front Med (Lausanne)       Date:  2021-05-12

5.  Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Lucia Liotti; Silvia Caimmi; Paolo Bottau; Roberto Bernardini; Fabio Cardinale; Francesca Saretta; Francesca Mori; Giuseppe Crisafulli; Fabrizio Franceschini; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2019-01-29

6.  Identification of drug-specific public TCR driving severe cutaneous adverse reactions.

Authors:  Ren-You Pan; Mu-Tzu Chu; Chuang-Wei Wang; Yun-Shien Lee; Francois Lemonnier; Aaron W Michels; Ryan Schutte; David A Ostrov; Chun-Bing Chen; Elizabeth Jane Phillips; Simon Alexander Mallal; Maja Mockenhaupt; Teresa Bellón; Wichittra Tassaneeyakul; Katie D White; Jean-Claude Roujeau; Wen-Hung Chung; Shuen-Iu Hung
Journal:  Nat Commun       Date:  2019-08-08       Impact factor: 14.919

Review 7.  Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions.

Authors:  Yueran Li; Pooja Deshpande; Rebecca J Hertzman; Amy M Palubinsky; Andrew Gibson; Elizabeth J Phillips
Journal:  Front Genet       Date:  2021-04-16       Impact factor: 4.599

8.  Association of natural killer cell dysfunction and recurrent Stevens-Johnson syndrome in a pediatric patient.

Authors:  Jason Casselman; John Venglarcik; Matt Bludorn; Leah Chernin; David Swender; Hiag Tcheurekjian; Robert Hostoffer
Journal:  Allergy Rhinol (Providence)       Date:  2013

9.  Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013.

Authors:  Oki Suwarsa; Wulan Yuwita; Hartati Purbo Dharmadji; Endang Sutedja
Journal:  Asia Pac Allergy       Date:  2016-01-27

10.  Comparative Renoprotective Effect of Febuxostat and Allopurinol in Predialysis Stage 5 Chronic Kidney Disease Patients: A Nationwide Database Analysis.

Authors:  Yun-Shiuan O Hsu; I-Wen Wu; Shang-Hung Chang; Cheng-Chia Lee; Chung-Ying Tsai; Chan-Yu Lin; Wan-Ting Lin; Yu-Tung Huang; Chao-Yi Wu; George Kuo; Chih-Yen Hsiao; Hsing-Lin Lin; Chih-Chao Yang; Tzung-Hai Yen; Yung-Chang Chen; Cheng-Chieh Hung; Ya-Chong Tian; Chang-Fu Kuo; Chih-Wei Yang; Gerard F Anderson; Huang-Yu Yang
Journal:  Clin Pharmacol Ther       Date:  2019-12-17       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.